Dr. Goldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
747 Broadway
Seattle, WA 98122Phone+1 206-215-2520Fax+1 206-386-3180
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2012 - 2015
- University of WashingtonResidency, Internal Medicine, 2008 - 2011
- Perelman School of Medicine at the University of PennsylvaniaClass of 2008
Certifications & Licensure
- WA State Medical License 2008 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study of Baricitinib (LY3009104) in Participants With COVID-19 Start of enrollment: 2020 Jun 12
Publications & Presentations
PubMed
- 1 citationsEfficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.Meghan E Sise, Jose Ramon Santos, Jason D Goldman, Katherine R Tuttle, J Pedro Teixeira
Clinical Infectious Diseases. 2024-11-22 - Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant.Matthew E Levy, Vanessa Chilunda, Richard E Davis, Phillip R Heaton, Pamala A Pawloski
The Journal of Infectious Diseases. 2024-11-15 - 1 citationsDifferentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.Kristine M Erlandson, Linda N Geng, Caitlin A Selvaggi, Tanayott Thaweethai, Peter Chen
Annals of Internal Medicine. 2024-09-01
Press Mentions
- New Research Evaluates the Safety of Transplants from Organ Donors Who Recently Testing Positive for SARS-CoV-2January 25th, 2023
- Vital Signs, Not Comorbidities, More Accurate Predictors of Death, Severe Illness for COVID PatientsMay 3rd, 2022
- Initial Vital Signs, Labs Better Predict COVID Severity Than Chronic ConditionsApril 28th, 2022
- Join now to see all
External Links
- NCBI publications: https://www.ncbi.nlm.nih.gov/myncbi/1puUjq7H-inAu/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: